Erik Bodor

Title: The Innovations of Erik Bodor

Introduction

Erik Bodor is an accomplished inventor based in Durham, NC (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel cholinergic receptor ligands. His work has implications for treating various disorders associated with cholinergic receptors.

Latest Patents

Erik Bodor holds a patent for "Aza-bridged bicyclic amine derivatives for use as novel cholinergic receptor ligands." This invention discloses novel cholinergic receptor ligands and relates to the synthesis of substituted derivatives of aza-bridged bicyclic amines. These compounds are designed for use as muscarinic receptor ligands, with methods for regulating the function of specific cholinergic receptors. The patent also addresses the potential for these ligands to act as antagonists, agonists, and partial agonists at certain cholinergic receptor subtypes. Furthermore, it outlines methods for treating disorders associated with cholinergic receptors. Erik Bodor has 1 patent to his name.

Career Highlights

Erik Bodor is affiliated with the University of North Carolina at Chapel Hill, where he continues to advance research in his field. His work has garnered attention for its innovative approach to drug development and receptor interaction.

Collaborations

Some of Erik Bodor's notable coworkers include T Kendall Harden and Myoung Goo Kim. Their collaborative efforts contribute to the ongoing research and development in the area of cholinergic receptor ligands.

Conclusion

Erik Bodor's contributions to the field of medicinal chemistry and his innovative patent on cholinergic receptor ligands highlight his role as a significant inventor. His work has the potential to impact the treatment of various disorders, showcasing the importance of innovation in healthcare.